Debt-to-equity of Cullinan Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cullinan Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Cullinan Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 5.8%, a 19% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cullinan Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 5.8% +0.94% +19% 30 Sep 2025
Q2 2025 5% -0.24% -4.6% 30 Jun 2025
Q1 2025 4.5% -1% -18% 31 Mar 2025
Q4 2024 4.6% -1.1% -19% 31 Dec 2024
Q3 2024 4.8% -0.39% -7.5% 30 Sep 2024
Q2 2024 5.2% +0.06% +1.2% 30 Jun 2024
Q1 2024 5.5% -1.2% -18% 31 Mar 2024
Q4 2023 5.7% -0.77% -12% 31 Dec 2023
Q3 2023 5.2% -0.86% -14% 30 Sep 2023
Q2 2023 5.2% -0.13% -2.4% 30 Jun 2023
Q1 2023 6.8% +4.2% +170% 31 Mar 2023
Q4 2022 6.4% +4.4% +224% 31 Dec 2022
Q3 2022 6.1% +3.6% +149% 30 Sep 2022
Q2 2022 5.3% 30 Jun 2022
Q1 2022 2.5% 31 Mar 2022
Q4 2021 2% 31 Dec 2021
Q3 2021 2.4% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.